<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28099609</article-id>
      <article-id pub-id-type="pmc">5193198</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20165138</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Premature ventricular contractions associated with isotretinoin
use<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Alan</surname>
            <given-names>Sevil</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#xDC;nal</surname>
            <given-names>Bet&#xFC;l</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yildirim</surname>
            <given-names>Ayt&#xFC;l</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff1"><label>1</label> Akdeniz University School of Medicine &#x2013; Antalya, Turkey</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1"><bold>Mailing address:</bold> Sevil Alan Akdeniz, Universtiy School
of Medicine, 07059 Konyaalti, Antalya, Turkey, E-mail:
<email>alan_sevil@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>6</issue>
      <fpage>820</fpage>
      <lpage>821</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Isotretinoin has been considered a unique drug for acne treatment. However, it is
associated with numerous adverse effects. Isotretinoin can trigger premature
ventricular contractions. This report describes a 33-year-old-woman who
presented with palpitations for 1 week while undergoing 1-month isotretinoin
treatment for mild-moderate facial acne. An electrocardiogram and Holter
monitoring showed premature ventricular contractions during isotretinoin
(Roaccutane, Roche) treatment. Isotretinoin-related premature ventricular
contractions were strongly suggested in this case due to the existence of
documented premature ventricular contractions on electrocardiograms and the
disappearance of these premature ventricular contractions two weeks after
termination of the treatment To the authors' knowledge, there has been 1
reported case of premature ventricular contractions linked to isotretinoin use;
this report describes a second such case.</p>
      </abstract>
      <kwd-group>
        <kwd>Arrhythmias, cardiac</kwd>
        <kwd>Isotretinoin</kwd>
        <kwd>Tachycardia, ventricular</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Isotretinoin (13-cis-retinoic acid), a retinoic acid derivative, is the most
effective drug in acne pathogenesis. It was first introduced in 1982 and has been
used ever since to treat acne and it belongs to the first generation of synthetic
13-cis retinoic acid compounds.<sup><xref rid="r1" ref-type="bibr">1</xref></sup>
Isotretinoin is indicated for severe acne and moderate acne.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> The classic recommended dose is 0.5
to 1.0 mg/kg/day for 6 months. <sup><xref rid="r2" ref-type="bibr">2</xref></sup>
The drug entails various side effects that impact on many systems in the body. The
most common side effects are: chelitis, xerosis, ocular sicca, arthralgia, myalgia,
headache and hyperlipidemia.<sup><xref rid="r3" ref-type="bibr">3</xref></sup>
Furthermore, there are reports on its adverse effects associated with the nervous,
musculoskeletal, ocular, gastrointestinal, hematological, psychiatric, and cardiac
systems.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Most of the
drug's side effects are probably predictable and dose-dependent, which has led to
improvement in variable dose regimens.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> Unfortunately, rare but significant side effects (including
depression, inflammatory bowel disease) may occur. Thus, careful monitoring is
necessary to improve clinical outcomes and minimize potential adverse
events.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Systemic
isotretinoin therapy may cause cardiac side effects on rare occasions, like atrial
tachycardia, sinus tachycardia and congenital heart disease.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> The literature includes 1 reported
case of PVCs linked to isotretinoin use.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> In this report, the authors describe a second case of premature
ventricular contractions (PVCs) linked to isotretinoin use.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 35-year-old female presented with mild-moderate acne on her face. She started
treatment with isotretinoin (Roaccutane<sup>&#xAE;</sup>, Roche, Basel,
Switzerland), at a dose of 30mg per day, for facial acne, which had lasted one
month. No indications of smoking or alcohol use featured in the patient's personal
history. Tests did not detect any other health problems, like hyperlipidemia,
diabetes, hypertension and congenital, or acquired heart disease. Shortly after
treatment was initiated, she complained of palpitations during exercise and rest.
Before, she had never experienced any episodes of palpitations or other symptoms
such as dizziness or chest pain. She consulted the Cardiology Department; her heart
sounds were arrhythmic upon cardiovascular examination. A 12-lead electrocardiogram
(ECG) showed premature ventricular contractions (PVCs) (<xref ref-type="fig" rid="f1">Figure 1</xref>). A transthoracic echocardiography revealed a normal
left and right ventricular size and function. Twenty-four-hour Holter monitoring
showed frequent single, bigeminy, trigeminy, quadrigeminy uniform PVCs.</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>The patient's 12-lead ECG during isotretinoin use</p>
          </caption>
          <graphic xlink:href="abd-91-06-0820-g01"/>
        </fig>
      </p>
      <p>When she was readmitted to the Cardiology Department two weeks after cessation of
isotretinoin treatment, her cardiovascular examination was normal. There were no
PVCs upon a 12-lead ECG and 24-hour Holter monitoring, or during exercise testing
(<xref ref-type="fig" rid="f2">Figure 2</xref>). She has remained asymptomatic
since the discontinuation of the drug.</p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>The patient's 12-lead ECG after discontinuation of the drug</p>
          </caption>
          <graphic xlink:href="abd-91-06-0820-g02"/>
        </fig>
      </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Isotretinoin is used to treat moderate to severe acne cases that are unresponsive to
conventional therapy.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Several
studies have been conducted to study the safety and efficacy of isotretinoin in
treating moderate to severe acne vulgaris.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup> According to case reports, systemic isotretinoin
therapy can cause cardiac side effects, like atrial tachycardia, congenital heart
disease, cardiac remodeling and sinus tachycardia.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> Charalabopoulos <italic>et al.</italic> described an
18-year old man who developed sinus tachycardia with transient right bundle branch
block after three months of isotretinoin treatment.<sup><xref rid="r7" ref-type="bibr">7</xref></sup> G&#xFC;ler E <italic>et al</italic> reported
pericardial effusion with atrial tachycardia due to isotretinoin use.<sup><xref rid="r5" ref-type="bibr">5</xref></sup>. There are limited reports on the
adverse cardiac effects of isotretinoin in literature. <sup><xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup></p>
      <p>Premature ventricular contractions (PVCs) are characterized by an early beat with a
wide and abnormal QRS complex, without a preceding P wave.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> The T wave axis is usually across from the QRS.
<sup><xref rid="r6" ref-type="bibr">6</xref></sup> PVCs can result from
hypoxia, hypovolemia, electrolyte abnormalities, medications, or irritation from
intracardiac monitoring or pacing catheters; it can also be idiopathic in
nature.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> The therapeutic
mechanism of retinoids and their side effects are not well defined.<sup><xref rid="r7" ref-type="bibr">7</xref></sup> Large doses of retinol result in
tissue damage due to the release of certain acid hydrolases and lysosomal enzymes
into circulation.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> The excess of
vitamin A causes considerable changes in heart electrogenesis (increased systole
duration and decreased diastole duration), mainly because of alterations in
myocardial cell membrane permeability.<sup><xref rid="r9" ref-type="bibr">9</xref></sup> Cell membrane fragility for myocardial cells may provide a
convincing explanation for the mechanism of PVCs.<sup><xref rid="r9" ref-type="bibr">9</xref></sup> Structural changes in the cell membrane affect action
potential, which may cause ventricular contractions.<sup><xref rid="r9" ref-type="bibr">9</xref></sup> The authors believe that the temporal relationship
between the isotretinoin treatment and the patient's documented arrhythmia on the
ECG and Holter suggests a drug-induced cause.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> The effect of isotretinoin on ventricular rhythm cannot be
discarded in this case. The report has highlighted a link between isotretinoin and
documented PVCs. Hence, clinicians should be conscious of the possible
arrhythmogenic effect(s) of isotretinoin and should be particularly careful with
individuals suffering from underlying heart disease.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at the Akdeniz University Hospital &#x2013; Antalya, Turkey.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Se&#xE7;kin</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Bas</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tak&#xE7;i</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Kalkan</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Effects of isotretinoin on the inflammatory markers and the
platelet counts in patients with acne vulgaris</article-title>
          <source>Cutan Ocul Toxicol</source>
          <year>2016</year>
          <volume>35</volume>
          <fpage>89</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">25853176</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Bhat</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Nandakishore</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dandakeri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Martis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kamath</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
          <article-title>Safety and efficacy of low-dose isotretinoin in the treatment of
moderate to severe acne vulgaris</article-title>
          <source>Indian J Dermatol</source>
          <year>2014</year>
          <volume>59</volume>
          <fpage>316</fpage>
          <lpage>316</lpage>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alli</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yorulmaz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>An unusual side effect of isotretinoin retinoid dermatitis
affecting external urethral meatus</article-title>
          <source>Cutan Ocul Toxicol</source>
          <year>2015</year>
          <volume>34</volume>
          <fpage>176</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">24964168</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>On</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Zeichner</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Isotretinoin updates</article-title>
          <source>Dermatol Ther</source>
          <year>2013</year>
          <volume>26</volume>
          <fpage>377</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="pmid">24099068</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xFC;ler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Babur G&#xFC;ler</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Yavuz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kizilirmak</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>An unknown side effect of isotretinoin pericardial effusion with
atrial tachycardia</article-title>
          <source>Anatol J Cardiol</source>
          <year>2015</year>
          <volume>15</volume>
          <fpage>168</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="pmid">25625453</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kili&#xE7;</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sahin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sahin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ozer</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Isotretinoin (13-cis-retinoic acid)-associated premature
ventricular contractions</article-title>
          <source>Turk J Pediatr</source>
          <year>2009</year>
          <volume>51</volume>
          <fpage>387</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="pmid">19950851</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charalabopoulos</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Papalimneou</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Charalabopoulos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hatzis</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Two new adverse effects of isotretinoin</article-title>
          <source>Br J Dermatol</source>
          <year>2003</year>
          <volume>148</volume>
          <fpage>593</fpage>
          <lpage>593</lpage>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ventura</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Ceriani</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zelaschi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rindi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Action potential modifications in rat myocardial cells induced by
hypervitaminosis A</article-title>
          <source>Q J Exp Physiol Cogn Med Sci</source>
          <year>1971</year>
          <volume>56</volume>
          <fpage>147</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="pmid">5208837</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Selcoki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Gorpelioglu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Turgut</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sarifakioglu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ozkara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tekin</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Isotretinoin is there any arrhythmic effect?</article-title>
          <source>Int J Dermatol</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>195</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="pmid">18211498</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
